Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors on strong trading day
The stock's rise snapped a four-day losing streak.
Corbus Pharmaceuticals Holdings Inc. stock underperforms Wednesday when compared to competitors
This was the stock's second consecutive day of losses.
HC Wainwright Has Bullish Forecast for CRBP Q1 Earnings
Equities research analysts at HC Wainwright boosted their Q1 2025 earnings per share (EPS) estimates for shares of Corbus Pharmaceuticals in a research note issued to investors on Wednesday, March ...
Zacks.com on MSN4d
After Plunging -22.69% in 4 Weeks, Here's Why the Trend Might Reverse for Corbus Pharmaceuticals (CRBP)
Corbus Pharmaceuticals (CRBP) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising ...
Investing6d
Corbus Pharmaceuticals appoints new COO
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP), a biopharmaceutical company with a market capitalization of $77 million, announced on Monday the appointment of Ian Hodgson as the new Chief ...
Nasdaq5d
After Plunging -22.9% in 4 Weeks, Here's Why the Trend Might Reverse for Corbus Pharmaceuticals (CRBP)
Corbus Pharmaceuticals (CRBP) has been on a downward spiral lately with significant selling pressure. After declining 22.9% over the past four weeks, the stock looks well positioned for a trend ...
William Blair Reaffirms Their Hold Rating on Terns Pharmaceuticals (TERN)
In a report released today, Andy Hsieh from William Blair reiterated a Hold rating on Terns Pharmaceuticals (TERN – Research Report). The ...
William Blair Reaffirms Their Buy Rating on Skye Bioscience (SKYE)
Detailed price information for Skye Bioscience Inc (SKYE-Q) from The Globe and Mail including charting and trades.
William Blair Sticks to Its Hold Rating for BioAge Labs, Inc. (BIOA)
Detailed price information for Bioage Labs Inc (BIOA-Q) from The Globe and Mail including charting and trades.